BlackRock Health Sciences Trust (BME)
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Industry: Asset Management
BlackRock Health Sciences Trust
NYSE:BMEFinancial Services · Asset Management
-0.92%$45.11
AH Close$45.11+0.00%vs close
AH Close$45.11+0.00%vs close
Mkt Cap$583.01M
Float12.92M
O/S12.92M
Inst Own20.0%
SI0.2%
Div Yield6.97%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$36.16M
Net Income$76.97M
Total Assets$570.14M
Free Cash Flow-$4.35M
Debt & Equity
Debt 0%
Equity 100%
Total Debt$894K
Total Equity$568.3M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in BME's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$570.14M
Liabilities$1.83M
Accounts Receivable$428K
Accounts Payable$212K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $36.16M | $24.07M | $34.9M | -$25.97M | $53.18M | $80.09M | $0 |
| YoY Growth | 50.2% | -31.0% | -234.4% | -148.8% | -33.6% | - | - |
| Cost of Revenue | $5.63M | $78 | $6.02M | $5.94M | $6.11M | $4.95M | $0 |
| Gross Profit | $30.53M | $24.07M | $28.87M | -$25.97M | $47.07M | $5.24M | $0 |
| Gross Margin | 84.4% | 100.0% | 82.7% | 100.0% | 88.5% | 6.5% | - |
| Research and Development | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $439K | $356K | $299K | $362K | $6.35M | $5.17M | $0 |
| Other | -$46.9M | $262K | $95K | -$26.33M | -$5.81M | $0 | $0 |
| Total Operating Expenses | -$46.46M | $617K | $394K | -$25.97M | $541K | $5.17M | $0 |
| Operating Income (EBIT) | $77M | $23.45M | $8.46M | -$26.46M | $59.12M | $79.56M | $0 |
| Operating Margin | 212.9% | 97.4% | 24.3% | 101.9% | 111.2% | 99.3% | - |
| Interest Expense | $46K | $78 | $55 | $0 | $0 | $0 | $0 |
| Interest Income | $7.72M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$28K | $0 | $11.55M | -$12K | -$8K | $79.56M | $0 |
| Income Before Tax (EBT) | $76.97M | $23.45M | $20.02M | -$26.47M | $59.12M | $79.56M | $0 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $76.97M | $23.45M | $20.02M | -$26.47M | $59.12M | $79.56M | $0 |
| Net Income Margin | 212.9% | 97.4% | 57.4% | 101.9% | 111.2% | 99.3% | - |
| Supplementary Data | |||||||
| EPS | 5.92 | 1.77 | 1.44 | -2.10 | 4.74 | 6.87 | 1.45 |
| Diluted EPS | 5.92 | 1.77 | 1.44 | -2.10 | 4.74 | 6.87 | 1.45 |
| Weighted Average OS | 13.00M | 13.26M | 13.94M | 12.61M | 112.88M | 112.70M | 112.70M |
| EBITDA | $77.01M | $23.45M | $20.02M | -$26.23M | $59.12M | $79.56M | $0 |
| EBITDA Margin | 213.0% | 97.4% | 57.4% | 101.0% | 111.2% | 99.3% | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $548 | $71K | $534 | $3K | $960 | $212K | $501K |
| Short-Term Investments | $4.92M | $26.49M | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $4.92M | $26.56M | $534 | $3K | $960 | $212K | $501K |
| Accounts Receivable | $428K | $1.2M | $1.58M | $2.37M | $3.18M | $376K | $574K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | -$1.2M | -$1.62M | -$2.37M | -$3.18M | -$183K | $0 |
| Total Current Assets | $5.34M | $26.56M | -$38K | $3K | $960 | $409K | $1.08M |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $564.78M | $773.33M | $594.4M | $603.68M | $645.54M | $553.11M | $1.72B |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $16K | -$223.36M | $596.1M | $2.45M | $3.27M | -$3.07B | $0 |
| Total Long-Term Assets | $564.79M | $549.96M | $594.4M | $606.13M | $648.81M | -$2.51B | $1.72B |
| Other Assets | $0 | $0 | $1.74M | $0 | $0 | $3.07B | $8.75M |
| Total Assets | $570.14M | $774.59M | $596.1M | $606.13M | $648.81M | $554.55M | $1.73B |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $212K | $493K | $0 | $233K | $12.48M | $114K | $0 |
| Short-Term Debt | $0 | $21K | $61K | $3K | $212K | $103K | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | -$920K | -$1.09M | -$682K | -$895K | -$900K | $7.92M | $1.52M |
| Total Current Liabilities | $0 | $0 | $0 | $0 | $12.48M | $8.62M | $1.52M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $894K | $152K | $61K | $3K | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $939K | $3.6M | $7.91M | $5.7M | $10.56M | $0 | $0 |
| Total Long-Term Liabilities | $1.83M | $3.75M | $7.97M | $5.7M | $10.56M | $0 | $0 |
| Other Liabilities | $0 | $4.24M | $7.97M | $5.93M | $23.04M | $0 | $93.49M |
| Total Liabilities | $1.83M | $6.03M | $7.97M | $5.93M | $23.04M | $8.62M | $93.49M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $357.61M | $942.1M | $417.62M | $424.3M | $390.51M | $339.11M | $1.52B |
| Retained Earnings | $210.69M | -$173.53M | $170.52M | $175.9M | $235.27M | $206.83M | $117.28M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $0 | $0 | $0 | $0 | $0 | $2.48B | $0 |
| Total Equity | $568.3M | $768.57M | $588.14M | $600.2M | $625.77M | $3.02B | $1.64B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $570.14M | $774.59M | $596.1M | $606.13M | $648.81M | $3.03B | $1.73B |
| Supplementary Data | |||||||
| Total Debt | $894K | $299K | $61K | $3K | $212K | $103K | $0 |
| Net Debt | $894K | -$71K | -$534 | -$3K | -$960 | -$109K | -$501K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | $76.97M | $23.45M | $20.02M | -$26.47M | $59.12M | $79.56M | $113.23M |
| Depreciation & Amortization | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | |||||||
| Accounts Receivable | -$25K | $216K | -$18K | -$147K | $5K | -$39K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $92K | -$20K | -$22K | -$4K | $0 | -$268K | $0 |
| Other Working Capital | $673K | $293K | -$748K | $476K | $241K | -$78K | $0 |
| Total Working Capital Change | $740K | $509K | -$765K | $325K | $246K | -$385K | $70.1M |
| Other Non-Cash Items | -$82.06M | $41.56M | $12.77M | $25.27M | -$80.92M | -$98.53M | -$1.7B |
| Net Cash from Operating | -$4.35M | $65.52M | $32.02M | -$874K | -$21.56M | -$19.35M | -$1.52B |
| Investing Activities | |||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$287.51M | -$169.97M | -$241.74M | -$244.08M | -$280.66M | -$133.08M | $0 |
| Sales of Investments | $324.81M | $236.39M | $276.51M | $232.46M | $280.63M | $132.11M | $0 |
| Other Investing Activities | $0 | -$66.41M | -$34.78M | $11.62M | $0 | $0 | $0 |
| Net Cash from Investing | $37.3M | $66.41M | $34.78M | -$11.62M | -$36K | -$970K | $0 |
| Financing Activities | |||||||
| Debt Repaid | - | $61K | - | - | - | - | - |
| Common Stock Issuance | $0 | $0 | $3.02M | $33.62M | $50.33M | $45.09M | $0 |
| Common Stock Repurchases | -$13.98M | -$29.53M | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$40.61M | -$35.92M | -$35.1M | -$32.73M | -$29M | -$25.65M | $0 |
| Other Financing Activities | $0 | $0 | -$497 | -$20K | $20K | $0 | $1.52B |
| Net Cash from Financing | -$54.59M | -$65.52M | -$32.02M | $876K | $21.34M | $19.44M | $1.52B |
| Forex Effect | $21.64M | -$7 | -$28 | $32 | -$1 | $0 | $19 |
| Net Change in Cash | -$6K | $6K | -$3K | $2K | -$211K | $86K | $9.15M |
| Supplementary Data | |||||||
| Operating Cash Flow | -$4.35M | $65.52M | $32.02M | -$874K | -$21.56M | -$19.35M | -$1.52B |
| Capital Expenditure | -$4 | $0 | -$3 | $0 | -$4 | -$3 | $0 |
| Free Cash Flow | -$4.35M | $65.52M | $32.02M | -$874K | -$21.56M | -$19.35M | -$1.52B |
| Cash at Beginning | $6K | $534 | $3K | $960 | $212K | $125K | $100K |
| Cash at End | $548 | $6K | $534 | $3K | $960 | $212K | $9.25M |